EMAIL THIS PAGE TO A FRIEND

Tissue engineering. Part A

Chondrogenesis of mesenchymal stem cells in an osteochondral environment is mediated by the subchondral bone.


PMID 23980750

Abstract

In articular cartilage repair, cells that will be responsible for the formation of repair tissue are often exposed to an osteochondral environment. To study cartilage repair mechanisms in vitro, we have recently developed a bovine osteochondral biopsy culture model in which cartilage defects can be simulated reproducibly. Using this model, we now aimed at studying the chondrogenic potential of human bone marrow-derived mesenchymal stem cells (hBMSCs) in an osteochondral environment. In contrast to standard in vitro chondrogenesis, it was found that supplementing transforming growth factor beta (TGFβ) to culture medium was not required to induce chondrogenesis of hBMSCs in an osteochondral environment. hBMSC culture in defects created in osteochondral biopsies or in bone-only biopsies resulted in comparable levels of cartilage-related gene expression, whereas culture in cartilage-only biopsies did not induce chondrogenesis. Subcutaneous implantation in nude mice of osteochondral biopsies containing hBMSCs in osteochondral defects resulted in the formation of more cartilaginous tissue than hBMSCs in chondral defects. The subchondral bone secreted TGFβ; however, the observed results could not be attributed to TGFβ, as either capturing TGFβ with an antibody or blocking the canonical TGFβ signaling pathway did not result in significant changes in cartilage-related gene expression of hBMSCs in the osteochondral culture model. Inhibition of BMP signaling did not prevent chondrogenesis. In conclusion, we demonstrate that chondrogenesis of hBMSCs is induced by factors secreted from the bone. We have strong indications that this is not solely mediated by members of the TGFβ family but other, yet unknown, factors originating from the subchondral bone appeared to play a key role.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

02487
Chloroform, analytical standard
CHCl3
48520-U
Chloroform, analytical standard
CHCl3
PHR1552
Chloroform, Pharmaceutical Secondary Standard; Certified Reference Material
CHCl3
D0700000
Dexamethasone, European Pharmacopoeia (EP) Reference Standard
C22H29FO5
1176007
Dexamethasone, United States Pharmacopeia (USP) Reference Standard
C22H29FO5
46165
Dexamethasone, VETRANAL, analytical standard
C22H29FO5
31375
Dexamethasone, tested according to Ph.Eur.
C22H29FO5
PHR1526
Dexamethasone, Pharmaceutical Secondary Standard; Certified Reference Material
C22H29FO5
Y0001593
Dexamethasone for peak identification, European Pharmacopoeia (EP) Reference Standard
C22H29FO5
Y0001177
Dexamethasone for system suitability, European Pharmacopoeia (EP) Reference Standard
C22H29FO5
49897
Formate standard for IC, 1.000 g/L in H2O, analytical standard
CH2O2
06473
Formic acid solution, BioUltra, 1.0 M in H2O
CH2O2
W326305
L-Cysteine, ≥97%, FG
C3H7NO2S
168149
L-Cysteine, 97%
C3H7NO2S
C7352
L-Cysteine, from non-animal source, BioReagent, suitable for cell culture, ≥98%
C3H7NO2S
C5360
L-Cysteine, PharmaGrade, from non-animal source, Ajinomoto, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture
C3H7NO2S
30089
L-Cysteine, BioUltra, ≥98.5% (RT)
C3H7NO2S
778672
L-Cysteine, produced by Wacker Chemie AG, Burghausen, Germany, ≥98.0%
C3H7NO2S
95437
L-Cysteine, certified reference material, TraceCERT®
C3H7NO2S
P0380
L-Proline, ReagentPlus®, ≥99% (HPLC)
C5H9NO2
P5607
L-Proline, from non-animal source, meets EP, USP testing specifications, suitable for cell culture
C5H9NO2
P8865
L-Proline, PharmaGrade, Ajinomoto, EP, JP, USP, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production, suitable for cell culture
C5H9NO2
1568506
L-Proline, United States Pharmacopeia (USP) Reference Standard
C5H9NO2
81709
L-Proline, BioUltra, ≥99.5% (NT)
C5H9NO2
93693
L-Proline, certified reference material, TraceCERT®
C5H9NO2
W331902
L-Proline, 99%, FCC, FG
C5H9NO2
PHR1332
L-Proline, Pharmaceutical Secondary Standard; Certified Reference Material
C5H9NO2
PHR1316
Residual Solvent - Chloroform, Pharmaceutical Secondary Standard; Certified Reference Material
CHCl3
PHR1416
Sodium Citrate, Pharmaceutical Secondary Standard; Certified Reference Material
C6H5Na3O7 · 2H2O